830.0500 -20.80 (-2.44%)
NSE Oct 13, 2025 15:31 PM
Volume: 228.8K
 

830.05
-2.44%
Geojit BNP Paribas
We upgrade our rating to Accumulate based on 10x FY22 EPS with a target of price of Rs.485 as new launches in U.S and other regulated markets will drive growth. Revenues were down 26% yoy and down 16% qoq mainly on...
Strides Pharma Scien.. has an average target of 1874.00 from 1 broker.
More from Strides Pharma Science Ltd.
Recommended